- Research Group Home Page:
- Work address:
- Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
POSEIDON phase 1b results: safety, efficacy and ctDNA response of taselisib combined with tamoxifen in hormone receptor positive metastatic breast cancer patients.
E-pub date: 31 Jul 2019
Cancer Treatment in the Genomic Era.
E-pub date: 28 Feb 2019
Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA.
E-pub date: 31 Dec 2018
- Show allHide all